How the Noninflammasome NLRs Function in the Innate Immune System
- 15 January 2010
- journal article
- review article
- Published by American Association for the Advancement of Science (AAAS) in Science
- Vol. 327 (5963), 286-290
- https://doi.org/10.1126/science.1184004
Abstract
NLR (nucleotide-binding domain, leucine-rich repeat–containing) proteins have rapidly emerged as central regulators of immunity and inflammation with demonstrated relevance to human diseases. Much attention has focused on the ability of several NLRs to activate the inflammasome complex and drive proteolytic processing of inflammatory cytokines; however, NLRs also regulate important inflammasome-independent functions in the immune system. We discuss several of these functions, including the regulation of canonical and noncanonical NF-κB activation, mitogen-activated protein kinase activation, cytokine and chemokine production, antimicrobial reactive oxygen species production, type I interferon production, and ribonuclease L activity. We also explore the mechanistic basis of these functions and describe current challenges in the field.Keywords
This publication has 48 references indexed in Scilit:
- Reduced -defensin expression is associated with inflammation and not NOD2 mutation status in ileal Crohn's diseaseGut, 2008
- Muramyl dipeptide activation of nucleotide-binding oligomerization domain 2 protects mice from experimental colitisJCI Insight, 2008
- Intracellular NOD-like Receptors in Host Defense and DiseaseImmunity, 2007
- Are innate immune signaling pathways in plants and animals conserved?Nature Immunology, 2005
- CATERPILLER: A Novel Gene Family Important in Immunity, Cell Death, and DiseasesAnnual Review of Immunology, 2005
- Nod2-Dependent Regulation of Innate and Adaptive Immunity in the Intestinal TractScience, 2005
- Nod2 Mutation in Crohn's Disease Potentiates NF-κB Activity and IL-1ß ProcessingScience, 2005
- NOD2 (CARD15) mutations in Crohn's disease are associated with diminished mucosal -defensin expressionGut, 2004
- NOD2 is a negative regulator of Toll-like receptor 2–mediated T helper type 1 responsesNature Immunology, 2004
- Gene–environment interaction modulated by allelic heterogeneity in inflammatory diseasesProceedings of the National Academy of Sciences of the United States of America, 2003